Chomarat Acquires CTMI to Deepen Capabilities in High-Performance Composite Textiles
BY Composights
Published: 28 Jan 2026
French technical textiles specialist Chomarat Group has finalized the acquisition of CTMI a company focused on
high-performance textiles and composite materials, reinforcing its strategic
position in advanced composite reinforcements.
The move expands Chomarat s expertise in specialty fibers
and engineered textile solutions critical to demanding composite applications
across aerospace, defense, and other high-performance markets, while
strengthening its ability to deliver differentiated reinforcement architectures
aligned with next-generation composite design requirements.
Expanded and Technology Leading Offerings
With a global presence in the composite materials
reinforcement market for several decades, CHOMARAT, a French family-owned
group, confirms its commitment to a long-term growth and development strategy
with this acquisition.
This acquisition allows CHOMARAT to complement its offerings and expertise in the field of composite material reinforcements, both in terms of fibers and technologies.
Thanks to this transaction, CHOMARAT becomes the only 100% French and independent player capable of offering a complete and sovereign range of technical textiles and high-performance composite materials for strategic markets such as aerospace, defense, and space.
Strong Complementary Expertise and Shared Values
This acquisition is based on a shared heritage. Both companies, which have their roots in silk manufacturing, have developed similar values: close collaboration and partnership, innovation, and responsible commitments.
Their merger aims to enrich their collective expertise and capitalize on their respective know-how.
CTMI will be able to rely on a solid group with strong values to pursue its development and implement its strategic roadmap. I am delighted with this agreement and look forward to collaborating with the teams at Groupe Chomarat, stated Lo c Alirand, President of GSL, CTMI s parent company.
